Header Logo

Connection

Yuki Kageyama to Drug Resistance, Neoplasm

Back to Details
This is a "connection" page, showing publications Yuki Kageyama has written about Drug Resistance, Neoplasm.
Yuki Kageyama
Connection Strength
0.054
Drug Resistance, Neoplasm
  1. The androgen receptor as putative therapeutic target in hormone-refractory prostate cancer. Recent Pat Anticancer Drug Discov. 2007 Nov; 2(3):203-11.
    View in: PubMed
    Score: 0.054
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.